CMPX Earnings

Quarterly EPS
$-0.08
Q3 2024
$-0.11
Q4 2024
$-0.12
Q1 2025
$-0.14
Q2 2025
$-0.08
Q3 2025
$-0.08
Q4 2025
$-0.10
Q1 2026
$-0.13
Q2 2026
Latest RevenueN/A
Latest Net Income-25154000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.130-25154000+7.1%
Q1 2026-$0.100-18317000+16.7%
Q4 2025-$0.080-15716000+27.3%
Q3 2025-$0.080-14259000+0.0%
Q2 2025-$0.140-19881000-100.0%-40.0%
Q1 2025-$0.120-16633000-50.0%
Q4 2024-$0.110-15033000+0.0%
Q3 2024-$0.080-10481000+0.0%
Q2 2024-$0.10850.0K-13076000
Q1 2024-$0.080-10787000
Q4 2023-$0.110-13415000
Q3 2023-$0.080-9964000
Compass Therapeutics (CMPX) — Earnings